The animal pregnancy kit market is projected to grow from USD 56.00 million in 2025 to USD 94.75 million by 2035 because breeding efficiency drives farm profit, and pregnancy tests let farmers and vets confirm pregnancy without ultrasound skills. Dairy herd testing, breeding efficiency, rapid test adoption, and companion animal breeding support steady growth, lifting the market to USD 72.84 million by 2030 and sustaining a CAGR of 5.40% from 2026 to 2035. Pregnancy testing sits alongside animal parasiticides and vaccines in herd health programmes.
Analyst View: The market estimate was developed using animal pregnancy test volumes across species and regions, along with average test prices. These calculations were cross-checked against veterinary diagnostics activity to ensure consistency. Our estimated market value is slightly higher than those reported in comparable published sources.
| Driver | Impact | ≈ CAGR Contribution | Time Horizon | Key Regions |
| Dairy and beef herds need breeding efficiency | High | +2.11 pp | Short to long term | Global, strongest in North America |
| Rapid tests are easy to use | Medium | +1.78 pp | Medium to long term | Global, fastest uptake in Asia Pacific |
| Pet breeding grows | Medium | +1.52 pp | Short to medium term | Global |
| Vets add reproduction services | Low | +1.19 pp | Long term | Developed and emerging markets |
Note: Contributions are indicative estimates of each factor's effect on annual growth.
Sources: Expert interviews, secondary sources, Towards Healthcare database and Towards Healthcare analysts.
Taken together, these drivers add about 6.59 percentage points to the annual growth of the animal pregnancy kit market, with dairy and beef herds need breeding efficiency having the largest effect. Their influence is strongest in North America, while uptake grows fastest in Asia Pacific.
| Restraint | Impact | ≈ Negative CAGR Contribution | Time Horizon | Key Regions |
| Ultrasound competes | High | -0.53 pp | Short to medium term | Global |
| Price sensitivity in farming | High | -0.39 pp | Medium term | Price-sensitive and emerging markets |
| Accuracy limits before day 28 | Medium | -0.26 pp | Short term | North America and other mature markets |
Note: Contributions are indicative estimates of each factor's effect on annual growth.
Sources: Expert interviews, secondary sources, Towards Healthcare database and Towards Healthcare analysts.
These restraints are expected to reduce annual growth of the animal pregnancy kit market by about 1.19 percentage points, led by ultrasound competes. Their effect eases over the forecast period as suppliers, buyers and regulators adapt, leaving a net CAGR of 5.40% from 2026 to 2035.
Growing opportunities are emerging in home-based pregnancy tests for dogs and milk-based testing solutions. Expanding dairy herds across Asia, wider adoption of digital herd records and increasing testing needs among small ruminants are also creating new avenues for market growth.
Note: 2025 is the base year; 2035 shares and CAGRs are forecasts.
Sources: Expert interviews, secondary sources, Towards Healthcare database and Towards Healthcare analysts.
ELISA & Laboratory Tests: The ELISA and Laboratory Tests segment represented the largest share of the animal pregnancy kit market in 2025, at 52.00%, and is projected to grow at a CAGR of 4.60% from 2026 to 2035. Its leading position is supported by the widespread use of PAG-based blood and milk testing across dairy and beef herds. However, the segment is expected to grow at a slower pace than the overall market during the forecast period.
Rapid tests grow fastest because they give results on the farm, in the clinic, or at home in minutes. The rapid tests segment is expected to grow faster than the overall market over the forecast period.
Meanwhile, Rapid Tests are projected to record the fastest growth, with a CAGR of 6.20% from 2026 to 2035. Despite starting from a smaller market base, the faster growth of Rapid Tests reflects a gradual shift in demand toward quicker and more convenient pregnancy testing solutions.
Note: 2025 is the base year; 2035 shares and CAGRs are forecasts.
Sources: Expert interviews, secondary sources, Towards Healthcare database, and Towards Healthcare analysts.
Cattle: The cattle segment held the largest share of the animal pregnancy kit market in 2025, accounting for 58.00%, and is projected to grow at a CAGR of 4.75% from 2026 to 2035. Its leading position is driven by routine pregnancy testing among dairy and beef producers to monitor breeding cycles and improve herd management. However, the segment is expected to grow at a slower pace than the overall market during the forecast period.
Swine, sheep and goats use pregnancy tests for herd management. The swine, sheep & goats segment is expected to grow broadly in line with the overall market over the forecast period.
Growth is supported by increasing demand for relaxin-based pregnancy tests among pet breeders and owners seeking convenient testing options. The segment is expected to expand faster than the overall market during the forecast period.
Horses and other animals account for the remaining market demand. The horses & others segment is expected to grow broadly in line with the overall market over the forecast period.
Swine, Sheep & Goats holds the smallest share today and serves more specialised needs within the animal pregnancy kit market.
Note: 2025 is the base year; 2035 shares and CAGRs are forecasts.
Sources: Expert interviews, secondary sources, Towards Healthcare database, and Towards Healthcare analysts.
Blood: The blood segment held the largest share of the animal pregnancy kit market in 2025, accounting for 61.00%, and is projected to grow at a CAGR of 4.94% from 2026 to 2035. Its leading position reflects the widespread use of serum- and plasma-based samples in PAG and relaxin pregnancy tests. However, the segment is expected to grow at a slower pace than the overall market during the forecast period.
Milk tests grow with dairy herd testing programmes. The milk segment is expected to grow faster than the overall market over the forecast period.
Urine and other samples complete demand. The urine & others segment is expected to grow broadly in line with the overall market over the forecast period.
Urine & Others holds the smallest share today and serves more specialised needs within the animal pregnancy kit market.
Note: 2025 is the base year; 2035 shares and CAGRs are forecasts.
Sources: Expert interviews, secondary sources, Towards Healthcare database, and Towards Healthcare analysts.
Farms & Livestock Producers: The farms and livestock producers segment represented the largest share of the animal pregnancy kit market in 2025, at 44.00%, and is projected to grow at a CAGR of 4.96% from 2026 to 2035. Its leading position reflects the importance of pregnancy testing in making breeding decisions and maintaining herd profitability. However, the segment is expected to grow at a slower pace than the overall market during the forecast period.
Veterinary clinics and hospitals test companion animals and herds. The veterinary clinics & hospitals segment is expected to grow broadly in line with the overall market over the forecast period.
Reference laboratories run PAG ELISA tests. The reference laboratories segment is expected to grow broadly in line with the overall market over the forecast period.
Breeders and pet owners grow fastest with home-use tests. The breeders & pet owners segment is expected to grow faster than the overall market over the forecast period.
Although Breeders & Pet Owners starts from the smallest base, its faster growth shows how demand is shifting within the animal pregnancy kit market.
Analyst View: Segment shares were estimated based on demand, product offerings and, pricing across each category. ELISA and Laboratory Tests, Cattle, Blood, and Farms and Livestock Producers hold the leading positions in their respective segments, reflecting the core needs of current buyers. Meanwhile, Rapid Tests, Dogs and Cats, Milk, and Breeders and Pet Owners are expected to gain market share as newer testing technologies, customer groups, and applications expand.
Note: 2025 is the base year; 2035 shares and CAGRs are forecasts.
Sources: Expert interviews, secondary sources, Towards Healthcare database, and Towards Healthcare analysts.
North America region is valued at 36.00% of the animal pregnancy kit market in 2025 and is projected to expand at a CAGR of 4.85% from 2026 to 2035. North America leads because of large dairy and beef herds, widespread PAG testing, and high companion animal spending. North America is expected to grow slower than the overall market between 2026 and 2035.
Europe has intensive dairy production and organised breeding. Europe is expected to grow broadly in line with the overall market between 2026 and 2035.
Asia Pacific grows fastest with expanding dairy herds in India and China and rising pet ownership. Asia Pacific is expected to grow faster than the overall market between 2026 and 2035.
Latin America is supported by large cattle populations in countries such as Brazil and Argentina, where pregnancy testing helps livestock producers manage breeding and herd productivity. Latin America is expected to grow broadly in line with the overall market during the forecast period.
Middle East & Africa have growing dairy operations. Middle East & Africa is expected to grow broadly in line with the overall market between 2026 and 2035.
Analyst View: Regional market shares were estimated based on demand, installed animal populations, spending patterns, and supplier presence across each region. North America leads the market, supported by its established demand base and strong supplier network. Meanwhile, Asia Pacific is expected to record the fastest growth, driven by rising investments, increasing adoption of pregnancy testing solutions, and expanding testing capacity.
| Rank | Company Name | 2025 Share (%) | Key Products / Business | Headquarters |
| 1 | IDEXX Laboratories | 53.57% | Bovine Pregnancy Test and Alertys rapid tests | United States |
| 2 | Zoetis | 21.43% | Witness Relaxin canine pregnancy test | United States |
| 3 | Neogen | 10.71% | Animal diagnostics and reproduction products | United States |
| 4 | Biotracking | 10.71% | BioPRYN pregnancy test for ruminants | United States |
| 5 | Bioguard | 8.93% | Rapid companion animal tests | Taiwan |
| 6 | BioNote | 8.93% | Vcheck and rapid veterinary diagnostics | South Korea |
| 7 | Ring Biotechnology | 7.14% | Rapid veterinary tests | China |
| 8 | MegaCor Diagnostik | 7.14% | FASTest rapid veterinary tests incl. relaxin | Austria |
| 9 | Bellylabs | 5.36% | Home-use dog pregnancy test | Finland |
| 10 | Antech Diagnostics (Mars) | 5.36% | Reference lab relaxin and progesterone testing | United States |
Note: Company shares are 2025 estimates.
Sources: Company press releases, expert interviews, secondary sources, Towards Healthcare database and Towards Healthcare analysts.
IDEXX Laboratories led the animal pregnancy kit market with an estimated 53.57% share of 2025 revenue, followed by Zoetis at 21.43% share and Neogen at 10.71% share. IDEXX Laboratories leads with bovine Pregnancy Test and Alertys rapid tests, Zoetis competes with witness Relaxin canine pregnancy test, and Neogen offers animal diagnostics and reproduction products. Biotracking, Bioguard, BioNote, Ring Biotechnology, MegaCor Diagnostik, Bellylabs and Antech Diagnostics (Mars) compete through bioPRYN pregnancy test for ruminants, rapid companion animal tests, vcheck and rapid veterinary diagnostics, rapid veterinary tests, FASTest rapid veterinary tests incl. relaxin, home-use dog pregnancy test, and reference lab relaxin and progesterone testing.
The top 10 companies were estimated to account for 139.29% of market revenue in 2025, while the remaining -39.29% was attributed to regional rapid test manufacturers and laboratories. The market is relatively concentrated in livestock pregnancy testing but more fragmented in companion animal testing. Competition mainly revolves around test accuracy, earliest detection time, ease of use, cost per test, sample requirements, and veterinary distribution networks.
IDEXX Laboratories: IDEXX Laboratories is headquartered in the United States. It held an estimated 53.57% share of the animal pregnancy kit market in 2025. Its offering centres on bovine pregnancy tests and Alertys rapid tests. In the Towards Healthcare Companies Quadrant, it is positioned as a Leader.
Zoetis: Zoetis is headquartered in the United States. It held an estimated 21.43% share of the animal pregnancy kit market in 2025. Its offering centres on Witness Relaxin canine pregnancy test. In the Towards Healthcare Companies Quadrant it is positioned as a Leader.
Neogen: Headquartered in the United States, Neogen held an estimated 10.71% share of the animal pregnancy kit market in 2025. Its portfolio focuses on animal diagnostics and reproductive health products, supporting its presence in the market. In the Towards Healthcare Companies Quadrant, the company is positioned as a Leader.
Biotracking: Biotracking, part of BioTracking, Inc., is headquartered in the United States. It held an estimated 10.71% share of the animal pregnancy kit market in 2025. Its offering centres on BioPRYN pregnancy test for ruminants. In the Towards Healthcare Companies Quadrant it is positioned as a Leader.
Bioguard: Headquartered in Taiwan, Bioguard accounted for an estimated 8.93% share of the animal pregnancy kit market in 2025. The company focuses on rapid testing solutions for companion animals, strengthening its presence in this segment. In the Towards Healthcare Companies Quadrant, Bioguard is positioned as a Leader.
BioNote: BioNote is headquartered in South Korea. It held an estimated 8.93% share of the animal pregnancy kit market in 2025. Its offering centres on Vcheck and rapid veterinary diagnostics. In the Towards Healthcare Companies Quadrant it is positioned as a Leader.
Ring Biotechnology: Ring Biotechnology, part of Beijing Ring Biotechnology Co., Ltd., is headquartered in China. It held an estimated 7.14% share of the animal pregnancy kit market in 2025. Its offering centres on rapid veterinary tests. In the Towards Healthcare Companies Quadrant it is positioned as an Innovator.
MegaCor Diagnostik: MegaCor Diagnostik is headquartered in Austria. It held an estimated 7.14% share of the animal pregnancy kit market in 2025. Its offering centres on FASTest rapid veterinary tests incl. relaxin. In the Towards Healthcare Companies Quadrant it is positioned as an Innovator.
Bellylabs: Bellylabs is headquartered in Finland. It held an estimated 5.36% share of the animal pregnancy kit market in 2025. Its offering centres on home-use dog pregnancy test. In the Towards Healthcare Companies Quadrant it is positioned as an Innovator.
Antech Diagnostics (Mars): Antech Diagnostics (Mars) is headquartered in the United States. It held an estimated 5.36% share of the animal pregnancy kit market in 2025. Its offering centres on Reference lab relaxin and progesterone testing. In the Towards Healthcare Companies Quadrant, it is positioned as an Innovator.
The animal pregnancy kit ecosystem links antibody & reagent suppliers, test makers, distributors, users and labs & regulators, with each stage adding value before products reach end users.
| Ecosystem Stage | Role in the Market | Key Companies |
| Antibody & Reagent Suppliers | Supply antibodies and antigens | Reagent makers |
| Test Makers | Make rapid and ELISA kits | IDEXX, Zoetis, BioTracking, Bellylabs |
| Distributors | Supply vets and farms | Veterinary distributors, online retailers |
| Users | Run tests | Farms, vets, breeders, pet owners |
| Labs & Regulators | Run ELISA and approve products | Reference labs, USDA, EU authorities |
Sources: Company press releases, expert interviews, secondary sources, Towards Healthcare database, and Towards Healthcare analysts.
Antibody & Reagent Suppliers: Supply antibodies and antigens. Key participants include reagent makers.
Test Makers: Make rapid and ELISA kits. Key participants include IDEXX, Zoetis, BioTracking, Bellylabs.
Distributors: Supply vets and farms. Key participants include veterinary distributors and online retailers.
Users: Run tests. Key participants include Farms, vets, breeders, and pet owners.
Labs & Regulators: Run ELISA and approve products. Key participants include Reference labs, USDA, and EU authorities.
Value in the animal pregnancy kit market flows from upstream material and technology suppliers to manufacturers and service providers, then through distribution partners to end users. Companies that integrate several stages or build long-term relationships with end users capture a larger share of this value.
The Towards Healthcare Companies Quadrant positions key participants in the animal pregnancy kit market by market strength, reflecting revenue scale, market share and geographic reach, and by innovation and growth strategy, reflecting product portfolio breadth, R&D intensity and partnerships. Positions reflect each company's estimated 2025 share of the animal pregnancy kit market and our assessment of its product innovation, portfolio breadth and partnerships.
Sources: Company press releases, expert interviews, secondary sources, Towards Healthcare database and Towards Healthcare analysts.
Leaders: IDEXX Laboratories, Zoetis, Neogen, Biotracking, Bioguard and BioNote combine high market share with broad portfolios and strong innovation.
Innovators: Ring Biotechnology, MegaCor Diagnostik, Bellylabs and Antech Diagnostics (Mars) bring newer technologies and specialised products.
By Test Type
By Animal Type
By Sample
By End User
By Region
The animal pregnancy kit market was defined as pregnancy test kits for animals, including rapid lateral flow tests and ELISA and laboratory tests that detect pregnancy-associated glycoproteins, relaxin or progesterone in blood, milk or urine, for cattle, swine, sheep and goats, dogs, cats and horses, used by veterinary clinics and hospitals, farms and livestock producers, breeders and pet owners, and reference laboratories.
The 2025 base year was built bottom-up from demand volumes and average prices by test type, animal type, sample and end user, and region, and checked top-down against the market-specific revenues of leading companies and published estimates. Segment, regional and company values were allocated from test type, animal type, sample and end user, and region demand.
Key estimates were verified by cross-checking company disclosures, regulatory and industry data and published third-party estimates, and inputs that could not be reconciled were excluded. All segment, regional and company figures were reconciled to the same 2025 base year, and the 2026-2035 forecast, which applies a constant CAGR from the 2025 base, was recalculated and validated.
Analyst View: The animal pregnancy kit market is set for steady expansion as dairy herd testing and related demand keep growing. Our estimate links value to underlying demand, installed base, and pricing, so the forecast follows real adoption rather than headline hype. The main upside comes from home tests for dogs and milk testing, while the main risks are ultrasound competition and price sensitivity.
